Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

AutismScreeningTool: bringing to market a digital tool to facilitate screening for autism

Objetivo

Current autism screening tools could be improved. They have typically been developed without input from autistic people or clinicians – limiting accessibility, relevance, and clinical applicability – and validated mainly on white males, reducing effectiveness for women and ethnic minorities. Screening tools also generally rely on subjective reports, which are prone to bias and recall errors, and may not necessarily capture the features that most reliably identify autism. As a result, current tools are contributing to over 125,000 unnecessary referrals in England each year, causing long delays in diagnosis – reaching 18 years in certain areas – and costing the NHS £200 million. AutismScreeningTool (AST) directly addresses these issues. Building on 15 years of research, we have co-designed a smartphone app with lived-experience experts that extracts objective movement-based indicators, and can distinguish autistic from non-autistic people with ≥91% accuracy across genders and ethnicities. This Proof of Concept project will advance AST from a validated research innovation to a scalable healthcare product through four aims: 1) engaging a UK-wide healthcare provider network, embedding clinician feedback to ensure seamless integration; 2) validating and refining the algorithm, interface, and support module to maximise efficacy across diverse populations; 3) consolidating commercial and regulatory foundations; and 4) delivering a targeted marketing and dissemination strategy to promote uptake. Delivery will be strengthened by links with Autistica (charity), University of Birmingham enterprise and national healthcare providers. Through these partnerships, AST will reduce unnecessary referrals, reduce healthcare service costs, and provide more efficient and equitable diagnostic access.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2025-POC

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

THE UNIVERSITY OF BIRMINGHAM
Aportación neta de la UEn
€ 150 000,00
Dirección
Edgbaston
B15 2TT Birmingham
Reino Unido
Región
West Midlands (England) West Midlands Birmingham
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos

Beneficiarios (1)